世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

制限酵素の世界市場:タイプ別(I、II、III、IV)、用途別(遺伝子工学、DNAマッピング、遺伝子配列決定、その他)、エンドタイプ別(スティッキーエンド、ブラントエンド)、ソース別(細菌、古細菌)、切断特異性別(アイソシゾマー、ネオシゾマー)、エンドユーザー別(医薬品・バイオテクノロジー企業、学術研究機関、その他)、地域、競争、予測&機会、2025年


Global Restriction Endonuclease Market By Type (I, II, III, IV), By Application (Genetic Engineering, DNA Mapping, Gene Sequencing and Others), By End Type (Sticky End, Blunt End), By Source (Bacteria, Archaea), By Cleavage Specificity (Isoschizomers, Neoschizomers), By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Others), By Region, Competition, Forecast & Opportunities, 2025

制限酵素の世界市場は、予測期間中に圧倒的なCAGRで成長することが予想されます。市場成長の主な要因は、バイオテクノロジー部門や製薬業界などの最終使用産業における研究開発活動への投資の増加です。さらに、... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2022年7月1日 US$4,900
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
116 英語

 

サマリー

制限酵素の世界市場は、予測期間中に圧倒的なCAGRで成長することが予想されます。市場成長の主な要因は、バイオテクノロジー部門や製薬業界などの最終使用産業における研究開発活動への投資の増加です。さらに、糖尿病や癌などの慢性的な健康障害の発生率の増加は、今後数年間で世界中の制限酵素市場の成長に良い影響を与えると予測されています。さらに、資金提供という点での政府支援の増加が、2025年までの市場成長を後押しすると予測されています。
制限酵素の世界市場は、タイプ、アプリケーション、エンドタイプ、ソース、切断、エンドユーザー、地域、企業に基づいて区分されます。タイプに基づいて、市場はタイプI、タイプII、タイプIII、タイプIVに分けることができます。そのうち、タイプIIセグメントは2019年まで最大の市場規模という点で市場を支配し、さらに予測期間中もそのリードを維持すると予想されます。この成長は、遺伝子クローニングやDNA断片化、分析など、日常的に行われる分子生物学的な用途で使用されていることに起因しています。また、これらの酵素はDNAを一定の位置で切断するため、小さく明確なDNA断片が生成され、遺伝子やゲノムの特性解析に役立つことから、今後数年間、タイプII制限酵素の成長を後押しすると予想されています。さらに、バイオテクノロジー企業による開発活動への投資の増加が、このセグメントの成長をさらに後押ししています。
制限酵素の世界市場で事業を展開している主な企業は、New England Biolabs、Thermo Fisher Scientific、Takara Bio、Sigma-Aldrich、Illumina、Agilent Technologies、Promega、Jena Biosciences、Genetix Biotech Asia Pvt.世界中の制限酵素市場で動作する企業は、市場でのシェアを拡大に向かってより焦点を当てています。例えば、これらの主要なプレーヤーは、ユーザーの要件を満たすために、新規技術の開発などの有機的な戦略を行っており、業界の高い競争力を作るために。
本レポートで考慮した年数
歴史的年数:2015年~2018年
基本年:2019年
推定年:2020年
予測年:2021年~2025年
本調査の目的
- 世界の制限酵素市場の市場規模を分析・予測する。
- タイプ、アプリケーション、エンドタイプ、ソース、切断、エンドユーザー、企業、地域分布に基づいて、世界の制限エンドヌクレアーゼ市場を分類・予測する。
- 世界の制限エンドヌクレアーゼ市場の促進要因と課題を特定する。
- 世界の制限酵素市場における拡張、新製品発表、M&Aなどの競合開発を調査する。
- 世界の制限酵素市場の価格分析を行う。
- 世界の制限酵素市場で活動する主要企業のプロフィールを特定し、分析する。
TechSci Researchはこの調査のために一次調査と徹底的な二次調査の両方を実施しました。当初、TechSci Researchは世界中の企業のリストを入手しました。その後、TechSci Researchは特定された企業に対して一次調査の調査を実施した。インタビューしながら、回答者には競合他社についても質問しました。この手法により、TechSci Research は、二次調査の制限により特定できなかった企業も含めることができました。TechSci Research は、新製品、販売チャネル、世界中のすべての主要なプレーヤーの存在を分析しました。
TechSci Researchは、様々なエンドユーザーセグメントのデータを記録し、将来的な予測を行うボトムアップアプローチを用いて、世界の制限酵素市場の市場規模を算出した。TechSci Researchは、これらの値を業界の専門家や企業の代表者から入手し、適切で全体的な市場規模を得るためにこれらの製品タイプやアプリケーションの履歴データの分析を通じて外部で検証しました。企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家向けプレゼンテーション、財務報告書など、さまざまな二次資料もTechSci Researchによって調査されました。
主な対象読者
- 制限酵素の企業およびその他の利害関係者
- 規制当局や政策立案者などの政府機関
- 制限酵素に関連する組織、フォーラム、アライアンス
- 市場調査会社およびコンサルティング会社
本調査は、企業やパートナー、エンドユーザーなどの業界関係者にとって重要ないくつかの重要な質問に対する回答を提供し、さらに投資の戦略や市場機会の活用を可能にする上で有用です。
レポートの範囲
本レポートでは、制限酵素の世界市場を、以下に詳述した業界動向に加えて、以下のカテゴリーに分類しています。
- 市場、タイプ別
o タイプI
o タイプII
o タイプIII
o タイプIV
- 市場、アプリケーション別
o 遺伝子工学
o DNAマッピング
o 遺伝子シークエンス
o その他
- 市場、エンドタイプ別
o Sticky End
o Blunt End
- 市場、ソース別
o バクテリア
o 古細菌
- 市場、開裂特異性別
o イソシキゾマー
ネオシゾマー
- 市場、エンドユーザー別
o 製薬会社、バイオテクノロジー会社
o アカデミックリサーチインスティチュート
o その他
- 市場、地域別
o 北米
米国
メキシコ
カナダ
o ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
o アジア太平洋地域
中国
インド
日本
韓国
オーストラリア
シンガポール
o 中東・アフリカ
南アフリカ共和国
サウジアラビア
UAE
o 南米
ブラジル
アルゼンチン
コロンビア
競合他社の状況
企業プロファイル。制限酵素の世界市場における主要企業の詳細分析。
利用可能なカスタマイズ。
TechSci Researchでは、与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供しています。このレポートでは、以下のカスタマイズが可能です。
企業情報
- 追加的な市場プレイヤーの詳細分析とプロファイリング(最大5社まで)。

ページTOPに戻る


目次

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Restriction Endonuclease Market
4. Executive Summary
5. Global Restriction Endonuclease Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Type (I, II, III, IV)
5.2.2. By Application ( Genetic Engineering, DNA Mapping, Gene Sequencing and Others)
5.2.3. By End Type (Sticky End, Blunt End)
5.2.4. By Source (Bacteria, Archaea)
5.2.5. By Cleavage Specificity (Isoschizomers, Neoschizomers)
5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Others)
5.2.7. By Company (2019)
5.2.8. By Region
5.3. Market Attractiveness Index
6. Asia-Pacific Restriction Endonuclease Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By End Type
6.2.4. By Source
6.2.5. By Cleavage Specificity
6.2.6. By End-User
6.2.7. By Country
6.3. Market Attractiveness Index
6.4. Asia-Pacific: Country Analysis
6.4.1. China Restriction Endonuclease Market Outlook
6.4.1.1. Market Size & Forecast
6.4.1.1.1. By Value
6.4.1.2. Market Share & Forecast
6.4.1.2.1. By Type
6.4.1.2.2. By Application
6.4.1.2.3. By End Type
6.4.1.2.4. By Source
6.4.1.2.5. By Cleavage Specificity
6.4.1.2.6. By End-User
6.4.2. India Restriction Endonuclease Market Outlook
6.4.2.1. Market Size & Forecast
6.4.2.1.1. By Value
6.4.2.2. Market Share & Forecast
6.4.2.2.1. By Type
6.4.2.2.2. By Application
6.4.2.2.3. By End Type
6.4.2.2.4. By Source
6.4.2.2.5. By Cleavage Specificity
6.4.2.2.6. By End-User
6.4.3. Japan Restriction Endonuclease Market Outlook
6.4.3.1. Market Size & Forecast
6.4.3.1.1. By Value
6.4.3.2. Market Share & Forecast
6.4.3.2.1. By Type
6.4.3.2.2. By Application
6.4.3.2.3. By End Type
6.4.3.2.4. By Source
6.4.3.2.5. By Cleavage Specificity
6.4.3.2.6. By End-User
6.4.4. South Korea Restriction Endonuclease Market Outlook
6.4.4.1. Market Size & Forecast
6.4.4.1.1. By Value
6.4.4.2. Market Share & Forecast
6.4.4.2.1. By Type
6.4.4.2.2. By Application
6.4.4.2.3. By End Type
6.4.4.2.4. By Source
6.4.4.2.5. By Cleavage Specificity
6.4.4.2.6. By End-User
6.4.5. Singapore Restriction Endonuclease Market Outlook
6.4.5.1. Market Size & Forecast
6.4.5.1.1. By Value
6.4.5.2. Market Share & Forecast
6.4.5.2.1. By Type
6.4.5.2.2. By Application
6.4.5.2.3. By End Type
6.4.5.2.4. By Source
6.4.5.2.5. By Cleavage Specificity
6.4.5.2.6. By End-User
6.4.6. Australia Restriction Endonuclease Market Outlook
6.4.6.1. Market Size & Forecast
6.4.6.1.1. By Value
6.4.6.2. Market Share & Forecast
6.4.6.2.1. By Type
6.4.6.2.2. By Application
6.4.6.2.3. By End Type
6.4.6.2.4. By Source
6.4.6.2.5. By Cleavage Specificity
6.4.6.2.6. By End-User
7. Europe Restriction Endonuclease Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By End Type
7.2.4. By Source
7.2.5. By Cleavage Specificity
7.2.6. By End-User
7.2.7. By Country
7.3. Market Attractiveness Index
7.4. Europe: Country Analysis
7.4.1. France Restriction Endonuclease Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Type
7.4.1.2.2. By Application
7.4.1.2.3. By End Type
7.4.1.2.4. By Source
7.4.1.2.5. By Cleavage Specificity
7.4.1.2.6. By End-User
7.4.2. Germany Restriction Endonuclease Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Type
7.4.2.2.2. By Application
7.4.2.2.3. By End Type
7.4.2.2.4. By Source
7.4.2.2.5. By Cleavage Specificity
7.4.2.2.6. By End-User
7.4.3. United Kingdom Restriction Endonuclease Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Type
7.4.3.2.2. By Application
7.4.3.2.3. By End Type
7.4.3.2.4. By Source
7.4.3.2.5. By Cleavage Specificity
7.4.3.2.6. By End-User
7.4.4. Italy Restriction Endonuclease Market Outlook
7.4.4.1. Market Size & Forecast
7.4.4.1.1. By Value
7.4.4.2. Market Share & Forecast
7.4.4.2.1. By Type
7.4.4.2.2. By Application
7.4.4.2.3. By End Type
7.4.4.2.4. By Source
7.4.4.2.5. By Cleavage Specificity
7.4.4.2.6. By End-User
7.4.5. Spain Restriction Endonuclease Market Outlook
7.4.5.1. Market Size & Forecast
7.4.5.1.1. By Value
7.4.5.2. Market Share & Forecast
7.4.5.2.1. By Type
7.4.5.2.2. By Application
7.4.5.2.3. By End Type
7.4.5.2.4. By Source
7.4.5.2.5. By Cleavage Specificity
7.4.5.2.6. By End-User
8. North America Restriction Endonuclease Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By End Type
8.2.4. By Source
8.2.5. By Cleavage Specificity
8.2.6. By End-User
8.2.7. By Country
8.3. Market Attractiveness Index
8.4. North America: Country Analysis
8.4.1. United States Restriction Endonuclease Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Type
8.4.1.2.2. By Application
8.4.1.2.3. By End Type
8.4.1.2.4. By Source
8.4.1.2.5. By Cleavage Specificity
8.4.1.2.6. By End-User
8.4.2. Mexico Restriction Endonuclease Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Type
8.4.2.2.2. By Application
8.4.2.2.3. By End Type
8.4.2.2.4. By Source
8.4.2.2.5. By Cleavage Specificity
8.4.2.2.6. By End-User
8.4.3. Canada Restriction Endonuclease Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Type
8.4.3.2.2. By Application
8.4.3.2.3. By End Type
8.4.3.2.4. By Source
8.4.3.2.5. By Cleavage Specificity
8.4.3.2.6. By End-User
9. South America Restriction Endonuclease Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By End Type
9.2.4. By Source
9.2.5. By Cleavage Specificity
9.2.6. By End-User
9.2.7. By Country
9.3. Market Attractiveness Index
9.4. South America: Country Analysis
9.4.1. Brazil Restriction Endonuclease Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Type
9.4.1.2.2. By Application
9.4.1.2.3. By End Type
9.4.1.2.4. By Source
9.4.1.2.5. By Cleavage Specificity
9.4.1.2.6. By End-User
9.4.2. Argentina Restriction Endonuclease Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Type
9.4.2.2.2. By Application
9.4.2.2.3. By End Type
9.4.2.2.4. By Source
9.4.2.2.5. By Cleavage Specificity
9.4.2.2.6. By End-User
9.4.3. Colombia Restriction Endonuclease Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Type
9.4.3.2.2. By Application
9.4.3.2.3. By End Type
9.4.3.2.4. By Source
9.4.3.2.5. By Cleavage Specificity
9.4.3.2.6. By End-User
10. Middle East and Africa Restriction Endonuclease Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By End Type
10.2.4. By Source
10.2.5. By Cleavage Specificity
10.2.6. By End-User
10.2.7. By Country
10.3. Market Attractiveness Index
10.4. MEA: Country Analysis
10.4.1. South Africa Restriction Endonuclease Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Type
10.4.1.2.2. By Application
10.4.1.2.3. By End Type
10.4.1.2.4. By Source
10.4.1.2.5. By Cleavage Specificity
10.4.1.2.6. By End-User
10.4.2. Saudi Arabia Restriction Endonuclease Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Type
10.4.2.2.2. By Application
10.4.2.2.3. By End Type
10.4.2.2.4. By Source
10.4.2.2.5. By Cleavage Specificity
10.4.2.2.6. By End-User
10.4.3. UAE Restriction Endonuclease Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Type
10.4.3.2.2. By Application
10.4.3.2.3. By End Type
10.4.3.2.4. By Source
10.4.3.2.5. By Cleavage Specificity
10.4.3.2.6. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1. Competition Outlook
13.2. Players Profiled (Leading Companies)
13.2.1. New England Biolabs
13.2.2. Thermo Fisher Scientific
13.2.3. Takara Bio
13.2.4. Sigma-Aldrich
13.2.5. Illumina
13.2.6. Agilent Technologies
13.2.7. Promega
13.2.8. Jena Biosciences
13.2.9. Genetix Biotech Asia Pvt. Ltd.
13.2.10. Roche
13.2.11. Merck
13.2.12. Pfizer
13.2.13. Amgen
13.2.14. Vertex Pharmaceuticals
13.2.15. BioMarin Pharmaceutical
13.2.16. PerkinElmer
13.2.17. Abcam
13.2.18. Abbexa
13.2.19. Sisco Research Laboratories Pvt Ltd
13.2.20. Nippon Gene
14. Strategic Recommendations
15. About Us & Disclaimer

 

ページTOPに戻る


 

Summary

Global restriction endonuclease market is expected to grow at a formidable CAGR during the forecast period. The key factor responsible for market growth is growing investment in research and development activities in end use industries such as biotechnology sector and pharmaceutical industry. Additionally, rising incidences of chronic health disorders like diabetes, cancer among others is anticipated to bode well for the growth of restriction endonuclease market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is projected to bolster the market growth through 2025.
The global restriction endonuclease market is segmented based on type, application, end type, source, cleavage, end-user, region and company. Based on type, the market can be segmented into Type I, Type II, Type III and Type IV. Out of which, the Type II segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its lead during the forecast years as well. This growth can be accredited to its use in molecular biology applications that are carried on everyday such as gene cloning and DNA fragmentation and analysis. Also, because these enzymes cleave DNA at fixed positions, therefore small, well-defined fragments of DNA are produced which assist in characterization of genes and genomes, thereby anticipated to boost the growth of Type II restriction endonucleases segment over the coming years. Moreover, increasing investments in development activities by biotechnology companies is further aiding the segmental growth.
Major players operating in the global restriction endonuclease market include New England Biolabs, Thermo Fisher Scientific, Takara Bio, Sigma-Aldrich, Illumina, Agilent Technologies, Promega, Jena Biosciences, Genetix Biotech Asia Pvt. Ltd., Roche, Merck, Pfizer, Amgen, Vertex Pharmaceuticals, BioMarin Pharmaceutical, PerkinElmer, Abcam, Abbexa, Sisco Research Laboratories Pvt Ltd, Nippon Gene. The companies operating in restriction endonuclease market across the globe are focussing more towards the expanding their share in the market. For instance, these key players are making organic strategies such as developing novel technologies in order to meet the requirements of users and to make the industry highly competitive.
Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025
Objective of the Study:
• To analyse and forecast the market size of global restriction endonuclease market.
• To classify and forecast global restriction endonuclease market based on type, application, end type, source, cleavage, end-user, company and regional distribution.
• To identify drivers and challenges for global restriction endonuclease market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global restriction endonuclease market.
• To conduct pricing analysis for global restriction endonuclease market.
• To identify and analyse the profile of leading players operating in global restriction endonuclease market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of global restriction endonuclease market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Restriction endonuclease companies and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to restriction endonuclease
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global restriction endonuclease market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Market, By Type:
o Type I
o Type II
o Type III
o Type IV
• Market, By Application:
o Genetic Engineering
o DNA Mapping
o Gene Sequencing
o Others
• Market, By End Type:
o Sticky End
o Blunt End
• Market, By Source:
o Bacteria
o Archaea
• Market, By Cleavage Specificity:
o Isoschizomers
o Neoschizomers
• Market, By End-User:
o Pharmaceutical and Biotechnology Companies
o Academic Research Institutes
o Others
• Market, By Region:
o North America
 United States
 Mexico
 Canada
o Europe
 Germany
 France
 United Kingdom
 Italy
 Spain
o Asia-Pacific
 China
 India
 Japan
 South Korea
 Australia
 Singapore
o Middle East and Africa
 South Africa
 Saudi Arabia
 UAE
o South America
 Brazil
 Argentina
 Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global restriction endonuclease market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Restriction Endonuclease Market
4. Executive Summary
5. Global Restriction Endonuclease Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Type (I, II, III, IV)
5.2.2. By Application ( Genetic Engineering, DNA Mapping, Gene Sequencing and Others)
5.2.3. By End Type (Sticky End, Blunt End)
5.2.4. By Source (Bacteria, Archaea)
5.2.5. By Cleavage Specificity (Isoschizomers, Neoschizomers)
5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Others)
5.2.7. By Company (2019)
5.2.8. By Region
5.3. Market Attractiveness Index
6. Asia-Pacific Restriction Endonuclease Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By End Type
6.2.4. By Source
6.2.5. By Cleavage Specificity
6.2.6. By End-User
6.2.7. By Country
6.3. Market Attractiveness Index
6.4. Asia-Pacific: Country Analysis
6.4.1. China Restriction Endonuclease Market Outlook
6.4.1.1. Market Size & Forecast
6.4.1.1.1. By Value
6.4.1.2. Market Share & Forecast
6.4.1.2.1. By Type
6.4.1.2.2. By Application
6.4.1.2.3. By End Type
6.4.1.2.4. By Source
6.4.1.2.5. By Cleavage Specificity
6.4.1.2.6. By End-User
6.4.2. India Restriction Endonuclease Market Outlook
6.4.2.1. Market Size & Forecast
6.4.2.1.1. By Value
6.4.2.2. Market Share & Forecast
6.4.2.2.1. By Type
6.4.2.2.2. By Application
6.4.2.2.3. By End Type
6.4.2.2.4. By Source
6.4.2.2.5. By Cleavage Specificity
6.4.2.2.6. By End-User
6.4.3. Japan Restriction Endonuclease Market Outlook
6.4.3.1. Market Size & Forecast
6.4.3.1.1. By Value
6.4.3.2. Market Share & Forecast
6.4.3.2.1. By Type
6.4.3.2.2. By Application
6.4.3.2.3. By End Type
6.4.3.2.4. By Source
6.4.3.2.5. By Cleavage Specificity
6.4.3.2.6. By End-User
6.4.4. South Korea Restriction Endonuclease Market Outlook
6.4.4.1. Market Size & Forecast
6.4.4.1.1. By Value
6.4.4.2. Market Share & Forecast
6.4.4.2.1. By Type
6.4.4.2.2. By Application
6.4.4.2.3. By End Type
6.4.4.2.4. By Source
6.4.4.2.5. By Cleavage Specificity
6.4.4.2.6. By End-User
6.4.5. Singapore Restriction Endonuclease Market Outlook
6.4.5.1. Market Size & Forecast
6.4.5.1.1. By Value
6.4.5.2. Market Share & Forecast
6.4.5.2.1. By Type
6.4.5.2.2. By Application
6.4.5.2.3. By End Type
6.4.5.2.4. By Source
6.4.5.2.5. By Cleavage Specificity
6.4.5.2.6. By End-User
6.4.6. Australia Restriction Endonuclease Market Outlook
6.4.6.1. Market Size & Forecast
6.4.6.1.1. By Value
6.4.6.2. Market Share & Forecast
6.4.6.2.1. By Type
6.4.6.2.2. By Application
6.4.6.2.3. By End Type
6.4.6.2.4. By Source
6.4.6.2.5. By Cleavage Specificity
6.4.6.2.6. By End-User
7. Europe Restriction Endonuclease Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By End Type
7.2.4. By Source
7.2.5. By Cleavage Specificity
7.2.6. By End-User
7.2.7. By Country
7.3. Market Attractiveness Index
7.4. Europe: Country Analysis
7.4.1. France Restriction Endonuclease Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Type
7.4.1.2.2. By Application
7.4.1.2.3. By End Type
7.4.1.2.4. By Source
7.4.1.2.5. By Cleavage Specificity
7.4.1.2.6. By End-User
7.4.2. Germany Restriction Endonuclease Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Type
7.4.2.2.2. By Application
7.4.2.2.3. By End Type
7.4.2.2.4. By Source
7.4.2.2.5. By Cleavage Specificity
7.4.2.2.6. By End-User
7.4.3. United Kingdom Restriction Endonuclease Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Type
7.4.3.2.2. By Application
7.4.3.2.3. By End Type
7.4.3.2.4. By Source
7.4.3.2.5. By Cleavage Specificity
7.4.3.2.6. By End-User
7.4.4. Italy Restriction Endonuclease Market Outlook
7.4.4.1. Market Size & Forecast
7.4.4.1.1. By Value
7.4.4.2. Market Share & Forecast
7.4.4.2.1. By Type
7.4.4.2.2. By Application
7.4.4.2.3. By End Type
7.4.4.2.4. By Source
7.4.4.2.5. By Cleavage Specificity
7.4.4.2.6. By End-User
7.4.5. Spain Restriction Endonuclease Market Outlook
7.4.5.1. Market Size & Forecast
7.4.5.1.1. By Value
7.4.5.2. Market Share & Forecast
7.4.5.2.1. By Type
7.4.5.2.2. By Application
7.4.5.2.3. By End Type
7.4.5.2.4. By Source
7.4.5.2.5. By Cleavage Specificity
7.4.5.2.6. By End-User
8. North America Restriction Endonuclease Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By End Type
8.2.4. By Source
8.2.5. By Cleavage Specificity
8.2.6. By End-User
8.2.7. By Country
8.3. Market Attractiveness Index
8.4. North America: Country Analysis
8.4.1. United States Restriction Endonuclease Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Type
8.4.1.2.2. By Application
8.4.1.2.3. By End Type
8.4.1.2.4. By Source
8.4.1.2.5. By Cleavage Specificity
8.4.1.2.6. By End-User
8.4.2. Mexico Restriction Endonuclease Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Type
8.4.2.2.2. By Application
8.4.2.2.3. By End Type
8.4.2.2.4. By Source
8.4.2.2.5. By Cleavage Specificity
8.4.2.2.6. By End-User
8.4.3. Canada Restriction Endonuclease Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Type
8.4.3.2.2. By Application
8.4.3.2.3. By End Type
8.4.3.2.4. By Source
8.4.3.2.5. By Cleavage Specificity
8.4.3.2.6. By End-User
9. South America Restriction Endonuclease Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By End Type
9.2.4. By Source
9.2.5. By Cleavage Specificity
9.2.6. By End-User
9.2.7. By Country
9.3. Market Attractiveness Index
9.4. South America: Country Analysis
9.4.1. Brazil Restriction Endonuclease Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Type
9.4.1.2.2. By Application
9.4.1.2.3. By End Type
9.4.1.2.4. By Source
9.4.1.2.5. By Cleavage Specificity
9.4.1.2.6. By End-User
9.4.2. Argentina Restriction Endonuclease Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Type
9.4.2.2.2. By Application
9.4.2.2.3. By End Type
9.4.2.2.4. By Source
9.4.2.2.5. By Cleavage Specificity
9.4.2.2.6. By End-User
9.4.3. Colombia Restriction Endonuclease Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Type
9.4.3.2.2. By Application
9.4.3.2.3. By End Type
9.4.3.2.4. By Source
9.4.3.2.5. By Cleavage Specificity
9.4.3.2.6. By End-User
10. Middle East and Africa Restriction Endonuclease Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By End Type
10.2.4. By Source
10.2.5. By Cleavage Specificity
10.2.6. By End-User
10.2.7. By Country
10.3. Market Attractiveness Index
10.4. MEA: Country Analysis
10.4.1. South Africa Restriction Endonuclease Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Type
10.4.1.2.2. By Application
10.4.1.2.3. By End Type
10.4.1.2.4. By Source
10.4.1.2.5. By Cleavage Specificity
10.4.1.2.6. By End-User
10.4.2. Saudi Arabia Restriction Endonuclease Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Type
10.4.2.2.2. By Application
10.4.2.2.3. By End Type
10.4.2.2.4. By Source
10.4.2.2.5. By Cleavage Specificity
10.4.2.2.6. By End-User
10.4.3. UAE Restriction Endonuclease Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Type
10.4.3.2.2. By Application
10.4.3.2.3. By End Type
10.4.3.2.4. By Source
10.4.3.2.5. By Cleavage Specificity
10.4.3.2.6. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1. Competition Outlook
13.2. Players Profiled (Leading Companies)
13.2.1. New England Biolabs
13.2.2. Thermo Fisher Scientific
13.2.3. Takara Bio
13.2.4. Sigma-Aldrich
13.2.5. Illumina
13.2.6. Agilent Technologies
13.2.7. Promega
13.2.8. Jena Biosciences
13.2.9. Genetix Biotech Asia Pvt. Ltd.
13.2.10. Roche
13.2.11. Merck
13.2.12. Pfizer
13.2.13. Amgen
13.2.14. Vertex Pharmaceuticals
13.2.15. BioMarin Pharmaceutical
13.2.16. PerkinElmer
13.2.17. Abcam
13.2.18. Abbexa
13.2.19. Sisco Research Laboratories Pvt Ltd
13.2.20. Nippon Gene
14. Strategic Recommendations
15. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオマス)の最新刊レポート

TechSci Research社のバイオマス分野での最新刊レポート

本レポートと同じKEY WORD(bacteria)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る